The biopharmaceutical company TRANSTHERA-B (02617) has announced the execution of a share repurchase transaction.
On July 21, 2026, the firm utilized approximately HK$1.14 million to buy back 111,000 of its own shares.
The biopharmaceutical company TRANSTHERA-B (02617) has announced the execution of a share repurchase transaction.
On July 21, 2026, the firm utilized approximately HK$1.14 million to buy back 111,000 of its own shares.
Comments